Skip to content
PubMed This is a summary of 12 peer-reviewed journal articles Updated
Neurology

Understanding Kufor-Rakeb Syndrome

At a Glance

Kufor-Rakeb syndrome is an ultra-rare inherited disorder caused by disease-causing changes in both copies of ATP13A2. Symptoms usually begin in youth and combine parkinsonism with cognitive and psychiatric changes; genetic testing helps confirm the diagnosis.

Getting a diagnosis of Kufor-Rakeb syndrome (KRS) often marks the end of a long and confusing journey. You may have spent years visiting different specialists, undergoing numerous tests, and receiving various labels for your symptoms before finally finding an answer [1] [2]. Understanding what this condition is—and how it affects the body and mind—is the first step in navigating life with a rare genetic disorder.

What is Kufor-Rakeb Syndrome?

Kufor-Rakeb syndrome is an ultra-rare, inherited neurological disorder that primarily affects movement and cognitive function [3]. It is named after the village in Jordan where it was first described in 1994. In the medical world, it is also known as PARK9, reflecting its place as a specific genetic form of parkinsonism [3] [4].

The condition is autosomal recessive, meaning a person must inherit two pathogenic (disease-causing) copies of the ATP13A2 gene—one from each parent—to develop the syndrome [5] [6]. For context, if both parents are carriers, each pregnancy has a 25% chance of an affected child, a 50% chance of a carrier, and a 25% chance of inheriting neither familial variant; testing relatives should always be targeted, voluntary, and guided by a genetics professional. Because it is so rare, many doctors may never see a case in their entire careers. While the exact number of people living with KRS worldwide is unknown, only a limited number of genetically confirmed cases have been reported in the medical literature across various global regions [7].

Typical Age of Onset

KRS is classified as a juvenile-onset or young-onset disorder. Symptoms usually begin during childhood, adolescence, or early adulthood, typically between the ages of 10 and 20, though onset can occur outside that window [8] [9]. Because it appears so early in life, it is often distinguished from the more common forms of Parkinson’s disease, which typically affect older adults.

The Features of KRS

The symptoms of KRS present as a variable spectrum, and they can vary significantly between individuals, even within the same family [3]. However, characteristic features generally include a combination of three main “pillars” of symptoms, though cognitive, psychiatric, and swallowing manifestations vary in their presence, timing, and severity:

  1. Progressive Parkinsonism: This refers to movement problems that resemble Parkinson’s disease, including tremors, stiffness (rigidity), and slowness of movement (bradykinesia) [7] [10].
  2. Cognitive Decline: Many individuals experience changes in thinking, memory, and problem-solving skills over time, which may eventually lead to dementia [10] [3].
  3. Psychiatric Symptoms: Behavioral and mental health changes can occur. These can include anxiety, hallucinations, or paranoid psychosis [11] [12]. In some cases, these psychiatric symptoms appear before any movement problems are noticed [11]. However, new hallucinations or psychosis should always prompt a review for reversible causes, as they can also be medication-related or caused by an acute medical problem.

Other Common Signs

Beyond the core features, doctors often look for several “atypical” signs that point specifically toward KRS:

  • Supranuclear Gaze Palsy: Difficulty moving the eyes, especially in an upward direction [3] [10].
  • Pyramidal Signs: Neurological indicators of “upper motor neuron” involvement, which can cause muscle spasticity or weakness [7] [3].
  • Minimyoclonus: Brief, involuntary “jerky” movements, often seen in the hands or face [10].

Navigating the Diagnostic Journey

Because KRS is so rare and its symptoms overlap with other conditions, it is frequently misdiagnosed at first. It is common for patients to be told they have hereditary spastic paraplegia (stiff muscles in the legs), ataxia (coordination problems), or even primary psychiatric disorders before genetic testing provides the definitive answer [1] [11] [2].

The process of reaching a diagnosis—often called a diagnostic odyssey—can be emotionally exhausting. Finally receiving a name for the condition can bring a complicated mix of relief at having an answer, and grief or fear regarding the future. Knowing that KRS is a genetic condition caused by the ATP13A2 gene means that the symptoms are not “your fault” and are not the result of anything you did; they are the result of a specific biological blueprint [5]. This clarity allows you and your medical team to focus on managing symptoms and improving quality of life.

Common questions in this guide

What causes Kufor-Rakeb syndrome, and how is it inherited?
Kufor-Rakeb syndrome is caused by disease-causing variants in both copies of the ATP13A2 gene. It follows an autosomal recessive pattern, so an affected person usually inherits one altered copy from each parent.
What symptoms are common in Kufor-Rakeb syndrome?
The main features are progressive parkinsonism, changes in thinking and memory, and psychiatric symptoms such as anxiety, hallucinations, or psychosis. Some people also develop difficulty moving the eyes, muscle stiffness or weakness, and brief jerky movements called minimyoclonus.
At what age do Kufor-Rakeb syndrome symptoms usually begin?
Symptoms most often start during childhood, adolescence, or early adulthood, commonly between ages 10 and 20. Onset can occur outside this age range, and symptoms may differ considerably from one person to another.
How is Kufor-Rakeb syndrome diagnosed?
Doctors assess the movement, thinking, psychiatric, and other neurological features, while considering conditions that can look similar. Genetic testing that identifies disease-causing ATP13A2 variants can provide the definitive confirmation.
Can psychiatric symptoms appear before movement problems in Kufor-Rakeb syndrome?
Yes. Anxiety, hallucinations, or psychosis may occur before noticeable movement changes in some people. New hallucinations or psychosis should also be evaluated for medication effects or other urgent, reversible medical causes.
How is Kufor-Rakeb syndrome different from typical Parkinson’s disease?
Kufor-Rakeb syndrome is a rare genetic form of parkinsonism that usually begins much earlier in life, often during the teenage years or early adulthood. Cognitive and psychiatric changes, eye-movement problems, and other neurological signs may also be prominent.

Get notified when new evidence is published on Kufor-Rakeb syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (12)
  1. 1

    Novel mutations in ATP13A2 associated with mixed neurological presentations and iron toxicity due to nonsense-mediated decay.

    Kırımtay K, Temizci B, Gültekin M, et al.

    Brain research 2021; (1750()):147167 doi:10.1016/j.brainres.2020.147167.

    PMID: 33091395
  2. 2

    Experience in the clinical and genetic diagnosis of a series of Algerian patients with hereditary spastic paraplegias.

    Messaoud-Khelifi M, Boulariah-Hadjou R, Kediha MI, et al.

    Neurogenetics 2025; (26(1)):52 doi:10.1007/s10048-025-00833-8.

    PMID: 40560206
  3. 3

    The role of ATP13A2 in Parkinson's disease: Clinical phenotypes and molecular mechanisms.

    Park JS, Blair NF, Sue CM

    Movement disorders : official journal of the Movement Disorder Society 2015; (30(6)):770-9 doi:10.1002/mds.26243.

    PMID: 25900096
  4. 4

    Hereditary Parkinsonism-Associated Genetic Variations in PARK9 Locus Lead to Functional Impairment of ATPase Type 13A2.

    Park JS, Sue CM

    Current protein & peptide science 2017; (18(7)):725-732 doi:10.2174/1389203717666160311121534.

    PMID: 26965689
  5. 5

    Kufor-Rakeb syndrome-associated psychosis: a novel loss-of-function ATP13A2 variant and response to antipsychotic therapy.

    Colijn MA, Vrijsen S, Au PYB, et al.

    Neurogenetics 2024; (25(4)):405-415 doi:10.1007/s10048-024-00767-7.

    PMID: 39023817
  6. 6

    Kufor-Rakeb Syndrome/PARK9: One Novel and One Possible Recurring Ashkenazi ATP13A2 Mutation.

    Inzelberg R, Estrada-Cuzcano A, Laitman Y, et al.

    Journal of Parkinson's disease 2018; (8(3)):399-403 doi:10.3233/JPD-181360.

    PMID: 29966207
  7. 7

    Kufor-Rakeb syndrome: a cohort-based clinical, imaging and genetic profile.

    Roy S, Mahale RR

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2026; (47(1)):106.

    PMID: 41493629
  8. 8

    Case Report: Novel ATP13A2 pathogenic variants associated with early-onset parkinsonism and a mini-review.

    Affronte L, Pini A, Pizzoli C, et al.

    Frontiers in genetics 2025; (16()):1588812 doi:10.3389/fgene.2025.1588812.

    PMID: 40799219
  9. 9

    Motor Neuron Involvement in Two ATP13A2-Related Families: ALS And HSP-Like Phenotypes.

    Khosravi S, Amini E, Emamikhah M, et al.

    Movement disorders clinical practice 2025; (12(6)):852-857 doi:10.1002/mdc3.70027.

    PMID: 40028680
  10. 10

    Clinical and ultrastructural findings in an ataxic variant of Kufor-Rakeb syndrome.

    Pietrzak A, Badura-Stronka M, Kangas-Kontio T, et al.

    Folia neuropathologica 2019; (57(3)):285-294 doi:10.5114/fn.2019.88459.

    PMID: 31588715
  11. 11

    Psychiatric Manifestations of ATP13A2 Mutations.

    Balint B, Damasio J, Magrinelli F, et al.

    Movement disorders clinical practice 2020; (7(7)):838-841 doi:10.1002/mdc3.13034.

    PMID: 33033738
  12. 12

    Action Myoclonus and Seizure in Kufor-Rakeb Syndrome.

    Rohani M, Lang AE, Sina F, et al.

    Movement disorders clinical practice 2018; (5(2)):195-199 doi:10.1002/mdc3.12570.

    PMID: 30868101

This page is for informational purposes only and does not constitute medical advice. Your neurologist and genetics professional should interpret your symptoms, genetic results, and care needs.